TickerFacts.

Atea Pharmaceuticals, Inc. (AVIR): Operating Income

Annual figures by period end, from SEC filings.

-$180.89M
Year ended 2025-12-31
-$183.61M
Trailing 12 months to 2026-06-30
$138.38M2018-12-31: -$9.48M2019-12-31: -$14.61M2020-12-31: -$11.03M2021-12-31: $138.38M2022-12-31: -$130.65M2023-12-31: -$164.16M2024-12-31: -$192.95M2025-12-31: -$180.89M-$180.89M
2018-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$180.89Mn/m2026-03-05, From 2025-01-01
2024-12-31-$192.95Mn/m2026-03-05, From 2024-01-01
2023-12-31-$164.16Mn/m2025-03-06, From 2023-01-01
2022-12-31-$130.65Mn/m2024-02-28, From 2022-01-01
2021-12-31$138.38Mn/m2023-02-28, From 2021-01-01
2020-12-31-$11.03Mn/m2023-02-28, From 2020-01-01
2019-12-31-$14.61Mn/m2022-02-28, From 2019-01-01
2018-12-31-$9.48Mn/a2021-03-30, From 2018-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31-$180.89Mn/m
ADC Therapeutics SA (ADCT)2025-12-31-$121.50Mn/m
Omeros Corp (OMER)2025-12-31-$122.80Mn/m
Sionna Therapeutics, Inc. (SION)2025-12-31-$88.98Mn/m
Prothena Corp Public Ltd Co (PRTA)2025-12-31-$214.64Mn/m
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31-$179.45Mn/m
Liquidia Corp (LQDA)2025-12-31-$51.38Mn/m
Rocket Pharmaceuticals, Inc. (RCKT)2025-12-31-$231.75Mn/m
Amylyx Pharmaceuticals, Inc. (AMLX)2025-12-31-$153.29Mn/m

Compare AVIR, ADCT, OMER, SION side by side · Screen every company in Pharmaceutical Preparations ↗